NCT03172598

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

A Phase IIa, Multi-Centre, Randomised, Double-Blind, Cross-Over, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy Incorporating an Open Label Pilot Arm

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: Tanabe Pharma Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A Study to Investigate the Safety, Tolerability and Efficacy of Multiple Doses of MT-8554 in Subjects with Painful Diabetic Peripheral Neuropathy

Conditions

• Painful Diabetic Peripheral Neuropathy

Interventions

Type	Name	Description
DRUG	MT-8554 low dose	Capsule
DRUG	MT-8554 middle dose	Capsule
DRUG	MT-8554 high dose	Capsule
DRUG	Placebo	Capsule

Timeline

• Start date: 2017-07-25
• Primary completion: 2018-08-08
• Completion: 2018-08-08
• First posted: 2017-06-01
• Last updated: 2025-12-22

Locations

3 sites across 3 countries: Germany, Hungary, Poland